• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall AIA900 Analyzer

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall AIA900 Analyzersee related information
Date Initiated by FirmSeptember 28, 2018
Create DateDecember 13, 2018
Recall Status1 Terminated 3 on September 03, 2020
Recall NumberZ-0600-2019
Recall Event ID 81190
Product Classification Fluorometer, for clinical use - Product Code KHO
ProductAIA-900Analyzer, Product code 022930, 022930R The AIA-2000 analyzer and AIA-900 analyzer are capable of performing three methods of immunoassay: an immunoenzymetric (IEMA) or sandwich immunoassay, a competitive binding (EIA) immunoassay, and a two-step immunoenzymetric immunoassay.
Code Information Affects all active analyzers. 022930, 022930R
FEI Number 3005529799
Recalling Firm/
Manufacturer
Tosoh Bioscience Inc
3600 Gantz Rd
Grove City OH 43123-1895
For Additional Information ContactMs. Bernadette O'Connell
800-248-6764
Manufacturer Reason
for Recall
Tosoh Bioscience has become aware of a potential issue with the AIA-900 and AIA-2000 analyzers that could result in slippage of the incubator unit contained within the system. If the tension of the timing belt is not adjusted correctly, it is possible for a misalignment that will result in a mechanical error. Tosoh has taken the required actions to inspect the tension of the timing belt during preventative maintenance and correct the instruments where this issue has been observed. If incubator slippage occurs, the unit will cease to function, and a system error will be reported. If this occurs, there may be a delay in testing and reporting patient test results. There have been no reports of injury related to this issue.
FDA Determined
Cause 2
Process control
ActionOn September 28, 2018, the firm, Tosoh Bioscience, notified consignees via an "URGENT: MEDICAL DEVICE RECALL" letter. The letter described the product, problem and actions to be taken. The letter informed customers that the AIA-900 and AIA -2000 analyzers had a potential issue that could result in slippage of the incubator unit within the system. Immediate Actions to be taken by the Customer/User " Thoroughly review the content of this letter. " Continue to use your Instrument. o Contact Tosoh Technical Support if mechanical errors occur. o The tension of the timing belt will be assessed and adjusted as needed at the next scheduled preventive maintenance visit. " Complete and return the attached Acknowledgement Form via Fax to: 1-605-636-8651; email: biorecallresponse@tosoh.com or mail to: Recall Coordinator, Tosoh Bioscience, Inc., 3600 Gantz Road, Grove City, OH 43123. " File this notice with your laboratory records and forward this information to others in your laboratory. If you have obtained unexpected test results, delays in test result reporting, or received any complaints of illness or adverse events associated with the use of the analyzer, please contact Tosoh Technical Support 24 hours a day, seven days a week at (800) 248-6764. Should you have any questions regarding this medical device recall, please feel free to call (800) 248-6764 or email: bernadette.oconnell@tosoh.com Monday - Friday, from 9:00 AM to 5:00 PM (PST).
Quantity in Commerce395
DistributionUS Nationwide distribution and International distribution to Colombia, Chile, Honduras, Cayman Islands, Panama, Costa Rica, Guatemala, Venezuela, Uruguay, Peru, and Ecuador.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-